<DOC>
	<DOCNO>NCT01871701</DOCNO>
	<brief_summary>To evaluate correct QT interval change ( automatic-reading ) single oral administration escitalopram , quetiapine moxifloxacin versus placebo healthy Korean Adults .</brief_summary>
	<brief_title>Clinical Trial Investigate Effect Corrected QT Interval Prolongation Psychotropic Drugs</brief_title>
	<detailed_description>Randomized , Open-label , Placebo-controlled , 4-way crossover study</detailed_description>
	<mesh_term>Psychotropic Drugs</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>1 . Healthy subject age 20 40 year . 2 . A body weight range 50 kg ( inclusive ) 90 kg ( inclusive ) body mass index ( BMI ) range 19.0 kg/m2 ( inclusive ) 25.0 kg/m2 ( inclusive ) . 3 . Sufficient ability understand nature study hazard participate . Provide write informed consent fully . inform study procedure . 1 . Presence history hypersensitivity allergic reaction drug include investigational product ( Escitalopram , Quetiapine , Moxifloxacin ) ) quinolone group antibiotic . 2 . Subject judge eligible study participation investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Corrected QT interval prolongation</keyword>
	<keyword>Psychotropic drug</keyword>
</DOC>